Back
Oramed Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
ORMP
Oramed Pharmaceuticals, Inc.
Last Price:
$3.24
Seasonality Move:
12.3%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and ORMP is experiencing slight buying pressure.
Oramed Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.32 | Sell |
| 20-day SMA: | 3.4 | Sell |
| 50-day SMA: | 3.19 | Buy |
| 200-day SMA: | 2.5 | Buy |
| 8-day EMA: | 3.13 | Buy |
| 20-day EMA: | 2.32 | Buy |
| 50-day EMA: | 1.27 | Buy |
| 200-day EMA: | 0.38 | Buy |
Oramed Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 47.15 | Sell |
| Chaikin Money Flow: | 8991 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.29 - 3.55) | Sell |
| Bollinger Bands (100): | (2.37 - 3.25) | Buy |
Oramed Pharmaceuticals, Inc. Technical Analysis
| Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Oramed Pharmaceuticals, Inc. Stock
Is Oramed Pharmaceuticals, Inc. Stock a Buy?
-
Oramed Pharmaceuticals, Inc. share price is 3.25 while ORMP 8-day simple moving average is 3.32, which is a Sell signal.
-
The stock price of ORMP is 3.25 while Oramed Pharmaceuticals, Inc. 20-day SMA is 3.40, which makes it a Sell.
-
Oramed Pharmaceuticals, Inc. 50-day simple moving average is 3.19 while ORMP share price is 3.25, making it a Buy technically.
-
ORMP stock price is 3.25 and Oramed Pharmaceuticals, Inc. 200-day simple moving average is 2.50, creating a Buy signal.
ORMP Technical Analysis vs Fundamental Analysis
Sell
45
Oramed Pharmaceuticals, Inc. (ORMP)
is a Sell
Is Oramed Pharmaceuticals, Inc. a Buy or a Sell?
-
Oramed Pharmaceuticals, Inc. stock is rated a SellThe current Oramed Pharmaceuticals, Inc. [ORMP] share price is $3.25. The Score for ORMP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Oramed Pharmaceuticals, Inc. Stock Info
Market Cap:
129.4M
Price in USD:
3.25
Share Volume:
62.9K
Oramed Pharmaceuticals, Inc. 52-Week Range
52-Week High:
3.71
52-Week Low:
1.82
Sell
45
Oramed Pharmaceuticals, Inc. (ORMP)
is a Sell
Oramed Pharmaceuticals, Inc. Share Price Forecast
-
What is the Oramed Pharmaceuticals, Inc. stock price today?The Oramed Pharmaceuticals, Inc. stock price is 3.25 USD today.
-
Will ORMP stock go up or go down?Oramed Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Oramed Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Oramed Pharmaceuticals, Inc. is overvalued.
Is Oramed Pharmaceuticals, Inc. Stock a Buy?
-
Oramed Pharmaceuticals, Inc. share price is 3.25 while ORMP 8-day exponential moving average is 3.13, which is a Buy signal.
-
The stock price of ORMP is 3.25 while Oramed Pharmaceuticals, Inc. 20-day EMA is 2.32, which makes it a Buy.
-
Oramed Pharmaceuticals, Inc. 50-day exponential moving average is 1.27 while ORMP share price is 3.25, making it a Buy technically.
-
ORMP stock price is 3.25 and Oramed Pharmaceuticals, Inc. 200-day simple moving average is 0.38, creating a Buy signal.
Technical Analysis of Oramed Pharmaceuticals, Inc.
Should I short Oramed Pharmaceuticals, Inc. stock?
-
ORMP Moving Average Covergence Divergence (MACD) indicator is 0.86, suggesting Oramed Pharmaceuticals, Inc. is a Buy
-
Oramed Pharmaceuticals, Inc. Relative Strength Index (RSI) is 47.15, which suggest Oramed Pharmaceuticals, Inc. is oversold
-
The Bollinger Bands (25) for Oramed Pharmaceuticals, Inc. is (3.29 - 3.55), which suggest Oramed Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Oramed Pharmaceuticals, Inc. is (2.37 - 3.25), which suggest Oramed Pharmaceuticals, Inc. is a Buy
* Oramed Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.